Low-dose IL-2 to treat Crohn’s disease flare-ups
Part of Digestive system clinical trials.
This trial tests a low dose of IL-2 to reduce inflammation and help control Crohn’s disease symptoms. It’s for people whose Crohn’s disease hasn’t responded to at least one standard treatment or who need steroids to stay under control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 12 to 80 (but people recruited at Boston Children’s may be up to 30).
- You have confirmed Crohn’s disease—not ulcerative colitis or indeterminate colitis.
- Your disease is active based on endoscopy (scope results show inflammation) and blood/other criteria.
- You tried at least one standard Crohn’s treatment and either did not improve or you can’t stop steroids.
- If you can become pregnant, you must use reliable birth control during the study and for 6 months after, and have a negative pregnancy test before starting.
- You must be able to sign consent (or your legal guardian can, if you’re under 18 or can’t consent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether a transplant using your own stem cells can calm active Crohn’s disease that hasn’t improved with standard medicines. It may help some people with ongoing inflammation and symptoms after multiple Crohn’s treatments.
This trial tests whether people with Crohn’s disease or ulcerative colitis who are currently well-controlled can safely use less-frequent anti-TNF medicine. It may help reduce treatment intensity while keeping inflammation under control.
This trial compares a steroid called prednisolone to a special diet (aCDED with PEN) for treating Crohn's disease flare-ups. It aims to see which approach helps improve quality of life.
This trial studies a combination of immune-suppressing treatments for children with Crohn’s disease that is not well controlled. It may help reduce inflammation and improve symptoms if you meet the study’s disease-activity and safety requirements.
This early-phase study tests whether a stem cell transplant can improve Crohn’s disease in teens and young adults whose disease is active and not responding to standard medicines. It may help some people who are not doing well despite several prior treatments, but it also involves intensive study procedures and safety checks.
This trial tests an experimental drug for people with moderate to severe Crohn's disease who haven't responded well to other treatments. The drug aims to reduce inflammation and may help improve symptoms.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.